In type 2 diabetes mellitus (T2DM), SGLT-2i can reduce the risk of HF that is unrelated to improved glycemic control; DPP-4i and GLP-1 RAs behave as neutral [7]. This evidence concerns the gene GLP1R and hydrops fetalis.